![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Pharmacokinetics of EVG/COBI/FTC/TDF Single Tablet Regimen following Treatment with EFV/FTC/TDF (Atripla) in Healthy Subjects
|
|
|
Reported by Jules Levin
13th HIV Clinical Pharmacology Intl Workshop
Apr 16-18 2012 Barcelona Spain
S Ramanathan, X Wei, J Custodio, H Wang, A Dave, A Cheng, and B Kearney
Gilead Sciences, Inc., Foster City, CA
![pharm1.gif](../images/052112/052112-3/pharm1.gif)
![pharm2.gif](../images/052112/052112-3/pharm2.gif)
![pharm3.gif](../images/052112/052112-3/pharm3.gif)
![pharm4.gif](../images/052112/052112-3/pharm4.gif)
![pharm5.gif](../images/052112/052112-3/pharm5.gif)
![pharm6.gif](../images/052112/052112-3/pharm6.gif)
![pharm7.gif](../images/052112/052112-3/pharm7.gif)
![pharm8.gif](../images/052112/052112-3/pharm8.gif)
![pharm9.gif](../images/052112/052112-3/pharm9.gif)
![pharm10.gif](../images/052112/052112-3/pharm10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|